Rappaport Reiches Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $513K | Buy |
69,075
+995
| +1% | +$7.39K | 0.13% | 60 |
|
|
2024
Q4 | $408K | Hold |
68,080
| – | – | 0.11% | 67 |
|
|
2024
Q3 | $349K | Hold |
68,080
| – | – | 0.09% | 74 |
|
|
2024
Q2 | $246K | Hold |
68,080
| – | – | 0.07% | 81 |
|
|
2024
Q1 | $219K | Hold |
68,080
| – | – | 0.07% | 94 |
|
|
2023
Q4 | $334K | Hold |
68,080
| – | – | 0.12% | 60 |
|
|
2023
Q3 | $371K | Hold |
68,080
| – | – | 0.16% | 51 |
|
|
2023
Q2 | $457K | Hold |
68,080
| – | – | 0.19% | 48 |
|
|
2023
Q1 | $601K | Hold |
68,080
| – | – | 0.27% | 40 |
|
|
2022
Q4 | $520K | Hold |
68,080
| – | – | 0.26% | 42 |
|
|
2022
Q3 | $485K | Hold |
68,080
| – | – | 0.25% | 41 |
|
|
2022
Q2 | $551K | Hold |
68,080
| – | – | 0.28% | 40 |
|
|
2022
Q1 | $945K | Hold |
68,080
| – | – | 0.5% | 28 |
|
|
2021
Q4 | $1.91M | Sell |
68,080
-65,250
| -49% | -$1.83M | 1.64% | 12 |
|
|
2021
Q3 | $4.53M | Hold |
133,330
| – | – | 4.48% | 4 |
|
|
2021
Q2 | $5.45M | Buy |
+133,330
| New | +$5.45M | 5.73% | 3 |
|